Literature DB >> 12761135

Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex.

Manabu Suzuki1, Tadakazu Hisamatsu, Daniel K Podolsky.   

Abstract

Although some intestinal epithelial cell lines are known to respond to lipopolysaccharide (LPS), understanding of the relationship between LPS responsiveness and the expression of LPS receptors or factors regulating LPS responsiveness of intestinal epithelial cell lines is incomplete. In this study, we demonstrate that commonly studied human intestinal epithelial cell lines can be classified into at least three different types on the basis of LPS responsiveness, Toll-like receptor-4 (TLR4) expression, and the effects of gamma interferon (IFN-gamma) on LPS responsiveness. The first phenotype, which includes the HCT-116 and Caco-2 cell lines, is characterized by relative hyporesponsiveness to LPS and diminished expression of TLR4 protein. In these cells, IFN-gamma does not induce LPS responsiveness. The second phenotype, which includes cell line SW480, exhibits a highly LPS-responsive phenotype and surface expression of TLR4 protein even in unprimed conditions. These lines are functionally similar to cells of monocytic lineage. In the third phenotype, which includes the HT-29 and Colo205 cell lines, TLR4 protein is largely present in the cytoplasmic fraction and the cells are hyporesponsive to LPS in an unprimed condition. However, priming of these cells with IFN-gamma can induce LPS responsiveness through augmentation of LPS uptake and expression of MD-2 mRNA and intracellular TLR4 proteins. Finally, these findings suggest that the Th1 cytokine IFN-gamma modulates LPS responsiveness through several mechanisms in intestinal epithelial cells and that these cells may comprise different subpopulations with distinct roles in innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761135      PMCID: PMC155722          DOI: 10.1128/IAI.71.6.3503-3511.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

Review 1.  Innate immunity.

Authors:  R Medzhitov; C Janeway
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

Review 2.  Inflammatory bowel disease (1)

Authors:  D K Podolsky
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

3.  Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors.

Authors:  E Cario; I M Rosenberg; S L Brandwein; P L Beck; H C Reinecker; D K Podolsky
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

4.  MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.

Authors:  R Dziarski; Q Wang; K Miyake; C J Kirschning; D Gupta
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 5.  Structure and function of Toll-like receptor proteins.

Authors:  T K Means; D T Golenbock; M J Fenton
Journal:  Life Sci       Date:  2000-12-08       Impact factor: 5.037

Review 6.  Innate immunity and the normal microflora.

Authors:  H G Boman
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

7.  Identification of a novel bacterial sequence associated with Crohn's disease.

Authors:  C L Sutton; J Kim; A Yamane; H Dalwadi; B Wei; C Landers; S R Targan; J Braun
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

8.  Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack.

Authors:  E S Bergmann-Leitner; S I Abrams
Journal:  Cancer Immunol Immunother       Date:  2000-07       Impact factor: 6.968

9.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

Authors:  J Pugin; C C Schürer-Maly; D Leturcq; A Moriarty; R J Ulevitch; P S Tobias
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease.

Authors:  R S Izzo; K Witkon; A I Chen; C Hadjiyane; M I Weinstein; C Pellecchia
Journal:  Scand J Gastroenterol       Date:  1993-04       Impact factor: 2.423

View more
  72 in total

1.  Prior thermal injury accelerates endotoxin-induced inflammatory cytokine production and intestinal nuclear factor-κB activation in mice.

Authors:  Nathan L Huber; Stephanie R Bailey; Rebecca Schuster; Cora K Ogle; Alex B Lentsch; Timothy A Pritts
Journal:  J Burn Care Res       Date:  2012 Mar-Apr       Impact factor: 1.845

Review 2.  Intestinal epithelial defense systems protect against bacterial threats.

Authors:  Bryan P Hurley; Beth A McCormick
Journal:  Curr Gastroenterol Rep       Date:  2004-10

3.  Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination.

Authors:  Michael de Vrese; Peter Rautenberg; Christiane Laue; Marion Koopmans; Tineke Herremans; Jürgen Schrezenmeir
Journal:  Eur J Nutr       Date:  2004-12-01       Impact factor: 5.614

Review 4.  Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

Authors:  E Cario
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

Review 5.  Toll-like receptors and the eye.

Authors:  Fu-Shin X Yu; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

6.  Enteroendocrine cells express functional Toll-like receptors.

Authors:  Milena Bogunovic; Shaival H Davé; Jeremy S Tilstra; Diane T W Chang; Noam Harpaz; Huabao Xiong; Lloyd F Mayer; Scott E Plevy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-03-29       Impact factor: 4.052

7.  Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells.

Authors:  S L Zunt; L V Burton; L I Goldblatt; E E Dobbins; M Srinivasan
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

8.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

9.  Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft.

Authors:  Yong Peng; Jian-Ping Gong; Chang-An Liu; Xu-Hong Li; Ling Gan; Shou-Bai Li
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

10.  Involvement of a Stat3 binding site in inflammation-induced enteric apelin expression.

Authors:  Song Han; Guiyun Wang; Xiang Qi; Ella W Englander; George H Greeley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-25       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.